Zuschrift von U.-D. Baumann & A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden: in: Strahlenther Onkol 2005;181:808–9 (Nr. 12) (DOI 10.1007/s00066-005-9449-3)

Zuschrift von U.-D. Baumann & A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden: in: Strahlenther Onkol 2005;181:808–9 (Nr. 12) (DOI 10.1007/s00066-005-9449-3)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Strahlentherapie und Onkologie 2006-05, Vol.182 (5), p.293-294
Hauptverfasser: Baumann, U.-D., Pfäfflin, A.
Format: Artikel
Sprache:ger
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 294
container_issue 5
container_start_page 293
container_title Strahlentherapie und Onkologie
container_volume 182
creator Baumann, U.-D.
Pfäfflin, A.
description
doi_str_mv 10.1007/s00066-006-9449-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_821769617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2226151631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c697-fc9d4ad8a93185b4ebb47e0e6f9d87572a8356017759884f57e30a47a9f82ea83</originalsourceid><addsrcrecordid>eNotkE1OwzAQRi0EEqVwAHYWC1Y42I0T2-xC-SlqJRAUgdhYbjIWqRqn2EmlIo7DTbgYKWXzzWKevtE8hI4ZjRil4jxQStOUdEEU54qsd1CP8VgRqtTrLupRJhQRLJH76CCEOaUs5Yr30NdbG_J3X9oGr2qHnyNyFeFL01bGOXyKswg_2J9vaxelw59thcd1VYFrjP_DpxEegfcb-AJnT9ljhusCPC5KwOPWheYMQ-kAvxjfwKIMDXQleAW-grIAd4j2rFkEOPqffTS9uZ4OR2Ryf3s3zCYkT5UgNlcFN4U0KmYymXGYzbgACqlVhRSJGBgZJ2n3oEiUlNwmAmJquDDKygF0yz462dYuff3RQmj0vG696y5qOWAiVSkTHcS2UO7rEDxYvfRlZfxaM6o3ivVWse5CbxTrdfwLBaZuOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>821769617</pqid></control><display><type>article</type><title>Zuschrift von U.-D. Baumann &amp; A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden: in: Strahlenther Onkol 2005;181:808–9 (Nr. 12) (DOI 10.1007/s00066-005-9449-3)</title><source>SpringerLink Journals - AutoHoldings</source><creator>Baumann, U.-D. ; Pfäfflin, A.</creator><creatorcontrib>Baumann, U.-D. ; Pfäfflin, A.</creatorcontrib><identifier>ISSN: 0179-7158</identifier><identifier>EISSN: 1439-099X</identifier><identifier>DOI: 10.1007/s00066-006-9449-y</identifier><language>ger</language><publisher>Heidelberg: Springer Nature B.V</publisher><ispartof>Strahlentherapie und Onkologie, 2006-05, Vol.182 (5), p.293-294</ispartof><rights>Urban &amp; Vogel München 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Baumann, U.-D.</creatorcontrib><creatorcontrib>Pfäfflin, A.</creatorcontrib><title>Zuschrift von U.-D. Baumann &amp; A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden: in: Strahlenther Onkol 2005;181:808–9 (Nr. 12) (DOI 10.1007/s00066-005-9449-3)</title><title>Strahlentherapie und Onkologie</title><issn>0179-7158</issn><issn>1439-099X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNotkE1OwzAQRi0EEqVwAHYWC1Y42I0T2-xC-SlqJRAUgdhYbjIWqRqn2EmlIo7DTbgYKWXzzWKevtE8hI4ZjRil4jxQStOUdEEU54qsd1CP8VgRqtTrLupRJhQRLJH76CCEOaUs5Yr30NdbG_J3X9oGr2qHnyNyFeFL01bGOXyKswg_2J9vaxelw59thcd1VYFrjP_DpxEegfcb-AJnT9ljhusCPC5KwOPWheYMQ-kAvxjfwKIMDXQleAW-grIAd4j2rFkEOPqffTS9uZ4OR2Ryf3s3zCYkT5UgNlcFN4U0KmYymXGYzbgACqlVhRSJGBgZJ2n3oEiUlNwmAmJquDDKygF0yz462dYuff3RQmj0vG696y5qOWAiVSkTHcS2UO7rEDxYvfRlZfxaM6o3ivVWse5CbxTrdfwLBaZuOQ</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Baumann, U.-D.</creator><creator>Pfäfflin, A.</creator><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>200605</creationdate><title>Zuschrift von U.-D. Baumann &amp; A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden</title><author>Baumann, U.-D. ; Pfäfflin, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c697-fc9d4ad8a93185b4ebb47e0e6f9d87572a8356017759884f57e30a47a9f82ea83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baumann, U.-D.</creatorcontrib><creatorcontrib>Pfäfflin, A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Strahlentherapie und Onkologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baumann, U.-D.</au><au>Pfäfflin, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zuschrift von U.-D. Baumann &amp; A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden: in: Strahlenther Onkol 2005;181:808–9 (Nr. 12) (DOI 10.1007/s00066-005-9449-3)</atitle><jtitle>Strahlentherapie und Onkologie</jtitle><date>2006-05</date><risdate>2006</risdate><volume>182</volume><issue>5</issue><spage>293</spage><epage>294</epage><pages>293-294</pages><issn>0179-7158</issn><eissn>1439-099X</eissn><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s00066-006-9449-y</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0179-7158
ispartof Strahlentherapie und Onkologie, 2006-05, Vol.182 (5), p.293-294
issn 0179-7158
1439-099X
language ger
recordid cdi_proquest_journals_821769617
source SpringerLink Journals - AutoHoldings
title Zuschrift von U.-D. Baumann & A. Pfäfflin zum Kommentar von T. Herrmann: ASARA oder die Kunst, eine Warteliste zu vermeiden: in: Strahlenther Onkol 2005;181:808–9 (Nr. 12) (DOI 10.1007/s00066-005-9449-3)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A06%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zuschrift%20von%20U.-D.%20Baumann%20&%20A.%20Pf%C3%A4fflin%20zum%20Kommentar%20von%20T.%20Herrmann:%20ASARA%20oder%20die%20Kunst,%20eine%20Warteliste%20zu%20vermeiden:%20in:%20Strahlenther%20Onkol%202005;181:808%E2%80%939%20(Nr.%2012)%20(DOI%2010.1007/s00066-005-9449-3)&rft.jtitle=Strahlentherapie%20und%20Onkologie&rft.au=Baumann,%20U.-D.&rft.date=2006-05&rft.volume=182&rft.issue=5&rft.spage=293&rft.epage=294&rft.pages=293-294&rft.issn=0179-7158&rft.eissn=1439-099X&rft_id=info:doi/10.1007/s00066-006-9449-y&rft_dat=%3Cproquest_cross%3E2226151631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=821769617&rft_id=info:pmid/&rfr_iscdi=true